BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33626243)

  • 1. High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer.
    Miao TW; Xiao W; Du LY; Mao B; Huang W; Chen XM; Li C; Wang Y; Fu JJ
    FEBS Open Bio; 2021 Apr; 11(4):1237-1249. PubMed ID: 33626243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.
    Bie T; Zhang X
    J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.
    Mateu-Jimenez M; Curull V; Rodríguez-Fuster A; Aguiló R; Sánchez-Font A; Pijuan L; Gea J; Barreiro E
    Clin Epigenetics; 2018; 10():7. PubMed ID: 29371906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative weighted molecular network construction from transcriptomics and genome wide association data to identify shared genetic biomarkers for COPD and lung cancer.
    Banaganapalli B; Mallah B; Alghamdi KS; Albaqami WF; Alshaer DS; Alrayes N; Elango R; Shaik NA
    PLoS One; 2022; 17(10):e0274629. PubMed ID: 36194576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel computational analysis of large transcriptome datasets identifies sets of genes distinguishing chronic obstructive pulmonary disease from healthy lung samples.
    Roessler FK; Benedikter BJ; Schmeck B; Bar N
    Sci Rep; 2021 May; 11(1):10258. PubMed ID: 33986404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of molecular mechanisms of chronic obstructive pulmonary disease.
    Chen W; Hong YQ; Meng ZL
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3557-63. PubMed ID: 25535123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Phosphoprotein 1 (SPP1) and Fibronectin 1 (FN1) Are Associated with Progression and Prognosis of Esophageal Cancer as Identified by Integrated Expression Profiles Analysis.
    Li M; Wang K; Pang Y; Zhang H; Peng H; Shi Q; Zhang Z; Cui X; Li F
    Med Sci Monit; 2020 Mar; 26():e920355. PubMed ID: 32208405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of related-genes of T cells in lung tissue of chronic obstructive pulmonary disease based on bioinformatics and experimental validation.
    Xue T; Dong F; Gao J; Zhong X
    Sci Rep; 2024 May; 14(1):12042. PubMed ID: 38802460
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang D; Yan Y; Hu F; Wang T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():167-175. PubMed ID: 32158203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of key miRNAs and potential mechanisms in non-small cell lung cancer development from chronic obstructive pulmonary disease.
    Denkçeken T; Pala E
    Gen Physiol Biophys; 2020 Jan; 39(1):69-77. PubMed ID: 32039826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Macrophage Polarization-Related Genes as Biomarkers of Chronic Obstructive Pulmonary Disease Based on Bioinformatics Analyses.
    Zhao Y; Li M; Yang Y; Wu T; Huang Q; Wu Q; Ren C
    Biomed Res Int; 2021; 2021():9921012. PubMed ID: 34250093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease.
    Wei L; Xu D; Qian Y; Huang G; Ma W; Liu F; Shen Y; Wang Z; Li L; Zhang S; Chen Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1103-9. PubMed ID: 26089660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.
    Berg J; Halvorsen AR; Bengtson MB; Taskén KA; Mælandsmo GM; Yndestad A; Halvorsen B; Brustugun OT; Aukrust P; Ueland T; Helland Å
    BMC Cancer; 2018 Jul; 18(1):739. PubMed ID: 30005623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Gene Expression Dataset Analysis Reveals Toll-Like Receptor Signaling Pathway is Strongly Associated With Chronic Obstructive Pulmonary Disease Pathogenesis.
    Dhamodharan P; Arumugam M
    COPD; 2020 Dec; 17(6):684-698. PubMed ID: 32757672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.
    Córdoba-Lanús E; Domínguez de-Barros A; Oliva A; Mayato D; Gonzalvo F; Remírez-Sanz A; Zulueta JJ; Celli B; Casanova C
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of dynamic signatures associated with smoking-related squamous cell lung cancer and chronic obstructive pulmonary disease.
    Sun X; Shang J; Wu A; Xia J; Xu F
    J Cell Mol Med; 2020 Jan; 24(2):1614-1625. PubMed ID: 31829519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer.
    Wang Y; Zheng K; Chen X; Chen R; Zou Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.
    Izquierdo JL; Resano P; El Hachem A; Graziani D; Almonacid C; Sánchez IM
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1053-8. PubMed ID: 25336937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.